Answers are grounded in this paper and cite their sources.
The articles provides an insight into the Horizon 2020 PANBioRA project, which aims to develop an integrated biomaterial risk assessment testing system. It consists of a modular system using cross-disciplinary techniques which will predict the patient-specific response to a given biomaterial. The testing system integrates different technologies (refined, miniaturised versions of existing methods and new evaluation technologies) into a single instrument that will be able to perform multiple analyses on cell and micro-tissue levels.
No takes yet. Share an insight, caveat, or question.
Ungemach et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: